NO904569L - Benzimidazolderivater og fremgangsmaate for deres fremstilling. - Google Patents

Benzimidazolderivater og fremgangsmaate for deres fremstilling.

Info

Publication number
NO904569L
NO904569L NO90904569A NO904569A NO904569L NO 904569 L NO904569 L NO 904569L NO 90904569 A NO90904569 A NO 90904569A NO 904569 A NO904569 A NO 904569A NO 904569 L NO904569 L NO 904569L
Authority
NO
Norway
Prior art keywords
group
procedures
preparation
derivatives
benzimidazold
Prior art date
Application number
NO90904569A
Other languages
English (en)
Other versions
NO904569D0 (no
NO177304C (no
NO177304B (no
Inventor
Takehiko Naka
Kohei Nishikawa
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of NO904569D0 publication Critical patent/NO904569D0/no
Publication of NO904569L publication Critical patent/NO904569L/no
Publication of NO177304B publication Critical patent/NO177304B/no
Publication of NO177304C publication Critical patent/NO177304C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/08Radicals containing only hydrogen and carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/12Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6503Five-membered rings
    • C07F9/6506Five-membered rings having the nitrogen atoms in positions 1 and 3
    • C07F9/65068Five-membered rings having the nitrogen atoms in positions 1 and 3 condensed with carbocyclic rings or carbocyclic ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Vascular Medicine (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Steroid Compounds (AREA)
NO904569A 1989-10-24 1990-10-23 Analogifremgangsmåte for fremstilling av terapeutisk aktive benzimidazolderivater NO177304C (no)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP27738589 1989-10-24
JP32897489 1989-12-18
JP514790 1990-01-11
JP9167590 1990-04-05
JP9732490 1990-04-11
JP11314590 1990-04-27

Publications (4)

Publication Number Publication Date
NO904569D0 NO904569D0 (no) 1990-10-23
NO904569L true NO904569L (no) 1991-04-25
NO177304B NO177304B (no) 1995-05-15
NO177304C NO177304C (no) 1995-08-23

Family

ID=27547894

Family Applications (1)

Application Number Title Priority Date Filing Date
NO904569A NO177304C (no) 1989-10-24 1990-10-23 Analogifremgangsmåte for fremstilling av terapeutisk aktive benzimidazolderivater

Country Status (14)

Country Link
US (1) US5128356A (no)
EP (1) EP0425921B1 (no)
JP (1) JP3099241B2 (no)
AT (1) ATE126219T1 (no)
AU (1) AU649418B2 (no)
CA (1) CA2028302C (no)
DE (1) DE69021502T2 (no)
FI (1) FI102068B (no)
HU (1) HUT55384A (no)
IE (1) IE67956B1 (no)
IL (1) IL95975A (no)
NO (1) NO177304C (no)
NZ (1) NZ235762A (no)
PT (2) PT95655B (no)

Families Citing this family (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3928177A1 (de) * 1989-04-08 1991-02-28 Thomae Gmbh Dr K Benzimidazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
GB8911854D0 (en) * 1989-05-23 1989-07-12 Ici Plc Heterocyclic compounds
IE70593B1 (en) * 1989-09-29 1996-12-11 Eisai Co Ltd Biphenylmethane derivative the use of it and pharmacological compositions containing same
DK0443983T3 (da) * 1990-02-19 1996-03-18 Ciba Geigy Ag Acrylforbindelser
FR2674523A1 (fr) * 1991-03-28 1992-10-02 Roussel Uclaf Nouveaux derives de benzimidazole, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant.
ATE171177T1 (de) * 1990-06-08 1998-10-15 Hoechst Marion Roussel Inc Benzimidazol-derivate, verfahren und zwischenprodukte zu ihrer herstellung, ihre anwendung als arzneimittel und diese enthaltende pharmazeutische zusammensetzungen
FR2670489B1 (fr) * 1990-12-18 1994-10-14 Roussel Uclaf Nouveaux derives de benzimidazole, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant.
RU1836357C (ru) * 1990-07-23 1993-08-23 Др.Карл Томэ ГмбХ Производные бензимидазола, их изомеры, смеси изомеров, гидраты или их физиологически переносимые соли, обладающие антагонистическими в отношении ангиотензина свойствами
DE4036706A1 (de) * 1990-11-17 1992-05-21 Hoechst Ag Verfahren zur behandlung der cardialen sowie der vasculaeren hypertrophie und hyperplasie
AU657498B2 (en) * 1990-12-14 1995-03-16 Novartis Ag Biphenylyl compounds
TW274551B (no) * 1991-04-16 1996-04-21 Takeda Pharm Industry Co Ltd
CA2068756A1 (en) * 1991-05-16 1992-11-17 Barry C. Ross Benzofuran derivatives
IL102183A (en) * 1991-06-27 1999-11-30 Takeda Chemical Industries Ltd The heterocyclic compounds are converted into biphenyl groups, their production and the pharmaceutical compositions containing them
TW300219B (no) * 1991-09-14 1997-03-11 Hoechst Ag
US5283242A (en) * 1991-10-24 1994-02-01 American Home Products Corporation Substituted benzimidazoles and quinazolines as antihypertensives
JP2682353B2 (ja) * 1991-11-20 1997-11-26 武田薬品工業株式会社 経口用医薬組成物およびその製造法
TW284688B (no) * 1991-11-20 1996-09-01 Takeda Pharm Industry Co Ltd
US5378701A (en) * 1991-12-27 1995-01-03 Kyowa Hakko Kogyo Tricyclic compounds
EP0549352B1 (en) * 1991-12-27 2000-03-01 Kyowa Hakko Kogyo Co., Ltd. Tricyclic compounds as angiotensin II antagonists
WO1993017682A1 (en) * 1992-03-04 1993-09-16 Abbott Laboratories Angiotensin ii receptor antagonists
US5605919A (en) * 1993-02-26 1997-02-25 Takeda Chemical Industries, Ltd. Treatment for viral diseases
CA2115985A1 (en) * 1993-02-25 1994-08-26 Kohei Nishikawa Vascular hypertrophy suppressor
JP2003306432A (ja) * 1993-04-22 2003-10-28 Takeda Chem Ind Ltd 腎疾患の予防または治療剤
JP3810020B2 (ja) 1993-04-22 2006-08-16 武田薬品工業株式会社 腎疾患の予防または治療剤
CA2125251C (en) 1993-06-07 2005-04-26 Yoshiyuki Inada A pharmaceutical composition for angiotensin ii-mediated diseases
US5721263A (en) * 1993-06-07 1998-02-24 Takeda Chemical Industries, Ltd. Pharmaceutical composition for angiotensin II-mediated diseases
CZ154994A3 (en) * 1993-07-02 1995-09-13 Senju Pharma Co Visual hypotensive agent
ZA945190B (en) * 1993-07-30 1995-02-24 Kotobuki Seiyaku Co Ltd Carboxymethylidenecycloheptimidazole derivatives method or manufacturing the same and therapeutic agents containing these compounds
US5753672A (en) * 1994-04-19 1998-05-19 Tanabe Seiyaku Co., Ltd. Imidazopyridine derivatives and process for preparing the same
AU679616B2 (en) * 1994-04-19 1997-07-03 Tanabe Seiyaku Co., Ltd. Imidazopyridine derivatives and process for preparing the same
CA2150610C (en) * 1994-06-01 1999-08-17 Mikiro Yanaka Benzene derivatives and pharmaceutical composition
AU677702B2 (en) * 1994-10-13 1997-05-01 Takeda Pharmaceutical Company Limited A prophylactic or therapeutic drug for renal diseases
HUP9901092A3 (en) * 1995-08-02 2001-11-28 Univ Newcastle Ventures Ltd Benzimidazole compounds and their pharmaceutical use
JP3166065B2 (ja) * 1996-02-08 2001-05-14 東京エレクトロン株式会社 処理装置及び処理方法
US6177587B1 (en) 1997-05-26 2001-01-23 Takeda Chemical Industries, Ltd. Production method of aminobenzene compound
BR9908474A (pt) 1998-03-04 2000-12-05 Takeda Chemical Industries Ltd Preparação de liberação prolongada, processo para a produção de uma preparação de liberação prolongada, e, composição farmacêutica
DE60037192T2 (de) 1999-07-21 2008-05-15 Takeda Pharmaceutical Co. Ltd. Mittel zur verbesserung der erkrankungen nach zerebralen durchblutungsstörungen sowie zur verhinderung deren fortschreitens
SE9903028D0 (sv) 1999-08-27 1999-08-27 Astra Ab New use
TWI265925B (en) 1999-10-11 2006-11-11 Pfizer Pyrazolo[4,3-d]pyrimidin-7-ones useful in inhibiting type 5 cyclic guanosine 3',5'-monophosphate phosphodiesterases(cGMP PDE5), process and intermediates for their preparation, their uses and composition comprising them
EP2062593A3 (en) 2000-12-01 2011-08-17 Takeda Pharmaceutical Company Limited Method for producing preparation containing bioactive peptide
CA2466659A1 (en) 2001-11-13 2003-05-22 Takeda Chemical Industries, Ltd. Anticancer agents
ES2407849T3 (es) * 2002-03-13 2013-06-14 Array Biopharma, Inc. Derivados de bencimidazol alquilados N3 como inhibidores de MEK
US7232828B2 (en) 2002-08-10 2007-06-19 Bethesda Pharmaceuticals, Inc. PPAR Ligands that do not cause fluid retention, edema or congestive heart failure
CA2542499A1 (en) 2003-10-16 2005-04-28 Teva Pharmaceutical Industries Ltd. Preparation of candesartan cilexetil
US7692023B2 (en) 2004-02-11 2010-04-06 Teva Pharmaceutical Industries Ltd. Candesartan cilexetil polymorphs
EP1742938A1 (en) * 2004-05-05 2007-01-17 Teva Pharmaceutical Industries Ltd. Preparation of candesartan cilexetil in high purity
DE102004060699A1 (de) * 2004-12-16 2006-06-22 Ratiopharm Gmbh Verfahren zur Herstellung von Candesartan
DK1863801T3 (da) * 2005-03-30 2010-11-15 Takeda Pharmaceutical Benzimidazolderivat og anvendelse deraf
EP1764365A1 (en) * 2005-09-20 2007-03-21 KRKA, D.D., Novo Mesto A process for the preparation of sartan derivates and intermediates useful in such process
CN101528262A (zh) 2006-08-10 2009-09-09 武田药品工业株式会社 药物组合物
KR20100031113A (ko) * 2007-05-24 2010-03-19 엘드러그 에스.에이. 1,(3),5-치환된 이미다졸, 이의 고혈압 치료 용도 및 이의 제조 방법
EP2170930B3 (en) 2007-06-04 2013-10-02 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
WO2009140111A1 (en) * 2008-05-15 2009-11-19 Merck & Co., Inc. Angiotensin ii receptor antagonists
JP2011522828A (ja) 2008-06-04 2011-08-04 シナジー ファーマシューティカルズ インコーポレイテッド 胃腸障害、炎症、癌、およびその他の障害の治療のために有用なグアニル酸シクラーゼのアゴニスト
AU2009270833B2 (en) 2008-07-16 2015-02-19 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
WO2010067912A1 (en) * 2008-12-12 2010-06-17 Pharmacostech Co., Ltd. Methods for preparing biphenyl benzoic acid derivatives
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
WO2012047538A1 (en) 2010-10-06 2012-04-12 Glaxosmithkline Llc Benzimidazole derivatives as pi3 kinase inhibitors
CN104428293B (zh) 2012-06-11 2018-06-08 Ucb生物制药私人有限公司 调节TNFα的苯并咪唑类
WO2014151206A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
CA2905435A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
EP2991644B1 (en) * 2013-04-04 2020-03-25 University of Maryland, Baltimore Nonsteroidal and steroidal compounds with potent androgen receptor down-regulation and anti prostate cancer activity
EP3004138B1 (en) 2013-06-05 2024-03-13 Bausch Health Ireland Limited Ultra-pure agonists of guanylate cyclase c, method of making and using same
US10364572B2 (en) 2014-08-30 2019-07-30 Innovative Building Technologies, Llc Prefabricated wall panel for utility installation
US10260250B2 (en) 2014-08-30 2019-04-16 Innovative Building Technologies, Llc Diaphragm to lateral support coupling in a structure
CZ2015687A3 (cs) 2015-10-02 2017-04-12 Zentiva, K.S. Farmaceutická kompozice obsahující kombinaci kandesartanu, amlodipinu a hydrochlorthiazidu
KR102279403B1 (ko) 2016-03-07 2021-07-21 이노베이티브 빌딩 테크놀러지스 엘엘씨 유틸리티 설치를 위한 미리 조립된 벽 패널
JP6786617B2 (ja) 2016-03-07 2020-11-18 イノベイティブ ビルディング テクノロジーズ,エルエルシー 外部導管係合特徴部を備えたプレハブ式間仕切り壁
AU2017229471B2 (en) 2016-03-07 2019-08-08 Innovative Building Technologies, Llc Waterproofing assemblies and prefabricated wall panels including the same
EP3426982A4 (en) 2016-03-07 2019-10-16 Innovative Building Technologies LLC FLOOR AND CEILING PANEL FOR PLATE-FREE FLOOR SYSTEM OF A BUILDING
JP7090069B2 (ja) * 2017-03-15 2022-06-23 住友ファーマ株式会社 重水素化ベンズイミダゾール化合物およびその医薬用途
US11098475B2 (en) 2017-05-12 2021-08-24 Innovative Building Technologies, Llc Building system with a diaphragm provided by pre-fabricated floor panels
US10323428B2 (en) 2017-05-12 2019-06-18 Innovative Building Technologies, Llc Sequence for constructing a building from prefabricated components
US10724228B2 (en) 2017-05-12 2020-07-28 Innovative Building Technologies, Llc Building assemblies and methods for constructing a building using pre-assembled floor-ceiling panels and walls
US10487493B2 (en) 2017-05-12 2019-11-26 Innovative Building Technologies, Llc Building design and construction using prefabricated components
JP7038004B2 (ja) 2018-05-24 2022-03-17 本田技研工業株式会社 光学部品の洗浄方法及び洗浄装置

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5671074A (en) * 1979-11-12 1981-06-13 Takeda Chem Ind Ltd 1,2-disubstituted-4-halogenoimidazole-5-acetic acid derivative
JPS5671073A (en) * 1979-11-12 1981-06-13 Takeda Chem Ind Ltd Imidazole derivative
US4612323A (en) * 1983-06-27 1986-09-16 Sumitomo Chemical Company, Limited Insecticidal and acaricidal derivatives of 1-benzylbenzimidazole
JPS61151176A (ja) * 1984-12-24 1986-07-09 Sumitomo Chem Co Ltd ベンズイミダゾール誘導体およびそれを有効成分とする殺虫、殺ダニ剤
US4812462A (en) * 1986-04-01 1989-03-14 Warner-Lambert Company 4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine-6-carboxylic acid analogs having antihypertensive activity
CA1334092C (en) * 1986-07-11 1995-01-24 David John Carini Angiotensin ii receptor blocking imidazoles
US4820843A (en) * 1987-05-22 1989-04-11 E. I. Du Pont De Nemours And Company Tetrazole intermediates to antihypertensive compounds
US5015651A (en) * 1988-01-07 1991-05-14 E. I. Du Pont De Nemours And Company Treatment of hypertension with 1,2,4-angiotensin II antagonists
US4880804A (en) * 1988-01-07 1989-11-14 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking benzimidazoles
JPH0273071A (ja) * 1988-09-09 1990-03-13 Sumitomo Chem Co Ltd ベンズイミダゾール誘導体、その製造法およびそれを有効成分とする殺虫、殺ダニ剤
DE3928177A1 (de) * 1989-04-08 1991-02-28 Thomae Gmbh Dr K Benzimidazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
CA2016710A1 (en) * 1989-05-15 1990-11-15 Prasun K. Chakravarty Substituted benzimidazoles as angiotensin ii antagonists
GB8911854D0 (en) * 1989-05-23 1989-07-12 Ici Plc Heterocyclic compounds
IE70593B1 (en) * 1989-09-29 1996-12-11 Eisai Co Ltd Biphenylmethane derivative the use of it and pharmacological compositions containing same

Also Published As

Publication number Publication date
NO904569D0 (no) 1990-10-23
AU649418B2 (en) 1994-05-26
US5128356A (en) 1992-07-07
NO177304C (no) 1995-08-23
PT101875B (pt) 1999-04-30
AU6461290A (en) 1991-05-02
IL95975A (en) 1997-06-10
PT95655B (pt) 1996-09-30
CA2028302A1 (en) 1991-04-25
IE903803A1 (en) 1991-04-24
IL95975A0 (en) 1991-07-18
ATE126219T1 (de) 1995-08-15
EP0425921A1 (en) 1991-05-08
EP0425921B1 (en) 1995-08-09
FI102068B1 (fi) 1998-10-15
CA2028302C (en) 2002-01-15
DE69021502T2 (de) 1996-01-11
PT95655A (pt) 1991-09-13
NZ235762A (en) 1992-04-28
JP3099241B2 (ja) 2000-10-16
FI905215A0 (fi) 1990-10-23
HU906539D0 (en) 1991-04-29
HUT55384A (en) 1991-05-28
JPH049373A (ja) 1992-01-14
FI102068B (fi) 1998-10-15
DE69021502D1 (de) 1995-09-14
PT101875A (pt) 1997-12-31
IE67956B1 (en) 1996-05-15
NO177304B (no) 1995-05-15

Similar Documents

Publication Publication Date Title
NO904569L (no) Benzimidazolderivater og fremgangsmaate for deres fremstilling.
DK0629609T3 (da) Fremgangsmåde til fremstilling af alkoxyiminoacetamidderivater og et mellemprodukt dertil
NO893453D0 (no) Antibakterielle spiro-forbindelser og fremgangsmaate for deres fremstilling.
AU5117890A (en) Trifluromethylphenylazolylmethyloxiranes, the preparation thereof and the use thereof as crop protection agents
ES8700228A1 (es) Un procedimiento para producir derivados de propargiloxiacetonitrilo sustituido.
ATE93232T1 (de) Bis(methylendioxy)biphenyl-verbindungen.
ES2043807T3 (es) Compuestos anticancer.
FI852223A0 (fi) Saosom fungicider anvaenda triazoler.
ES2038710T3 (es) Un procedimiento de preparacion de un derivado de benzoxazina y su utilizacion.
ATE69605T1 (de) Azolylpropenyl- und azolylmethyloxiran-derivate und diese enthaltende fungizide.
DK23089A (da) Thioformamidderivater og deres anvendelse
FR2354326A1 (fr) Nouveaux 3-(alkyl oxygene)-1,9-dihydroxy (ou 1-hydroxy-9-ceto)-dibenzo (b,d) pyrannes a activite analgesique
ATE105565T1 (de) Pradimicinderivate.
ES2024332A6 (es) Procedimiento para la obtencion de nuevas sulfonamidas.
ES2012695A6 (es) Un procedimiento para la preparacion de 4-(6'-metoxi -2'- naftil)-but-3-en -2-ona.
DK0391673T3 (da) Fremstilling af glutarsyrederivater
ES8500937A1 (es) Un procedimiento de preparacion de nuevos benzopirano-(2,3-d)-v-triazoles.
MY104164A (en) Heterocyclic compounds.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN APRIL 2003